The effect of community health volunteer activation on maternal and child health in Volta region, Ghana
| ISRCTN | ISRCTN49236178 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN49236178 |
| Protocol serial number | N/A |
| Sponsor | Korea International Cooperation Agency (KOICA) |
| Funder | Korea International Cooperation Agency |
- Submission date
- 15/05/2015
- Registration date
- 16/06/2015
- Last edited
- 10/07/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Background and study aims
Although there has been a decrease in mortality (deaths) of children under 5, there were still 44 such deaths for every 1,000 live birth around the world reported in 2013. Around 800 women worldwide die every day from pregnancy and childbirth related causes. In 2013, the under-5 children mortality rate in Ghana was 71.4 (per 1,000 live birth), which is higher than the global average. Furthermore, 2,143 women in Ghana died in pregnancy in 1990 and 2,343 were reported dead in 2013. Malaria is a significant cause of death among both children under 5 and pregnant women. Diarrhoea is also a major cause of death among children under 5 in Ghana. A number of previous studies have reported the effect of community-based health care on maternal and child health and a Community-based Health Planning and Services (CHPS) in Ghana was thoroughly designed and applied nationally to respond to the significant shortage of health workers and to improve maternal and child health. The experimental phase of CHPS introduction manifested the effect of engaging volunteer in the system, but emphasis and support on community health volunteers (CHV) in CHPS implementation has been diminished. Recently, the importance of the CHV role in CHPS is being re-emphasized and brought into the political discussion. We expect that it is a timely and significant work to provide scientific evident to support the effect of CHVs on the promotion of health in Ghana. Here, we want to examine the effect of using CHVs in the communities on maternal and child health, through experimental research. Main outcomes of the study are improvement of contraception, maternal health and child health through prevention and treatment services focused on malaria and diarrhoea.
Who can participate?
Households with a woman aged 15-49 with at least one live birth in the past 5 years, a child under 5, and living in 40 communities of Ketu South district, Volta region in Ghana.
What does the study involve?
Communities under 9 CHPS zones are randomly selected and allocated into either the treatment or control group. In the intervention group, CHVs are given proper training, material support, incentives and regular monitoring. They are trained to promote contraception, ante-natal and post-natal care, prevention of diarrhoea in children under 5 through hand-washing and latrine management and prevention of malaria through appropriate use of mosquito net both in children under 5 and pregnant women. CHVs also provide oral dehydration solutions (ORS) for children under 5 experiencing diarrhoea and rapid diagnostic test for malaria to those experiencing suspected fever. Accordingly, the use of CHVs are expected to promote health-related awareness and ultimately encourage healthy behaviours.
What are the possible benefits and risks of participating?
We expect that the community members, especially women in fertility and children of the intervention group will show improved health outcome. Fertile women will benefit by using proper contraception to avoid unwanted pregnancy and to meet the family planning needs. Pregnant women will have more timely treatment thanks to rapid diagnostic test provided by CHVs in the community. Children under 5 will less likely develop malaria and diarrhoea due to regular health promotion and education as well as get proper management when experiencing symptoms. The same targets in the control group will be also benefit after the first phase of the trial. We expect no risks to participating in the study.
Where is the study run from?
Communities under 9 CHPS zones in Ketu South district, Volta region in Ghana
When is the study starting and how long is it expected to run for?
February 2015 to September 2016
Who is funding the study?
Korea International Cooperation Agency (KOICA)
Who is the main contact?
Mr Gyuhong Lee
ghlee@koica.go.kr
Contact information
Public
825 Daewangpangyo-ro
Sujeong-gu
Seongnam-si
Gyeonggi-do
461-833
Korea, South
| Phone | +82 (0)31 740 0387 |
|---|---|
| ghlee@koica.go.kr |
Scientific
#301,1057-3
Namhyeon-dong
Gwanak-gu
Seoul
151-800
Korea, South
| 0000-0003-3557-4920 | |
| Phone | +82 (0)10 7628 3569 |
| yeonjima@gmail.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Phase-in study cluster randomized controlled trial |
| Secondary study design | Cluster randomised trial |
| Study type | Participant information sheet |
| Scientific title | The effect of community health volunteer activation on maternal and child health in Volta region, Ghana: a cluster randomized controlled trial |
| Study objectives | Community Health Volunteer (CHV) activation promotes maternal and child health. |
| Ethics approval(s) | Ghana Health Service Ethics Review Committee, 16/07/2015, ref: GHS-ERC 07/01/15 |
| Health condition(s) or problem(s) studied | Maternal and child health including family planning, malaria, diarrhoea |
| Intervention | Activation of CHV is the main intervention of the trial and the intervention will be applied to the intervention group for a year from August 2015 to September 2016 and to the communities under control group for 5 months after completion of intervention to the treatment group. 40 communities were randomly selected from 61 communities under 9 Community-based Health Planning and Services (CHPS) compounds in the study area. They will be allocated to each treatment and control group with restricted randomization method. We expect CHVs to be activated through provision of training, appropriate equipment for activity, incentives and regular monitoring. Main tasks of CHVs will be home visits to assigned households, support to community health nurse (CHN) activity in the community and outreach program, participation in the monthly review meeting at CHPS with CHNs and other CHVs, regular reporting and surveillance. Home-based counselling and care through home visit is a key activity of CHVs. They will deliver key messages to promote health-related perception and behavior, and deliver preventive and curative services to improve specific health outcomes. Key messages that will be delivered by CHVs include promotion of injectable and implant for contraception, delivery by a skilled birth attendant, utilization of mosquito net, proper hand-washing at 4 critical points, management of latrine and constant check on child's growth. Preventive and curatives measures that CHVs are allowed to take are provision of ORS to the under-5 children experiencing diarrhoea and examination of fever with thermometer and malaria with rapid diagnostic test. Initial training for CHVs will be consist of 5 day program with theoretical and field training. Further refresher training is planned to strengthen the capacity of CHVs. In order to support activities of CHVs, necessary tools and material incentives will be provided. Equipment list includes rain coat, ID card, logbook, notepad, digital thermometer, educational materials and others. Incentives are composed of phone credit to facilitate theirs communication with the mothers and CHNs and some food items. CHVs are encouraged to participate in the monthly review meeting held by CHNs at CHPS to report and share the progress and challenges. Process evaluation will be carried out throughout the study period to monitor and assess implementation of the interventions by household survey, key documentation review and observation. Four times of household survey is planned and review of key documentations such as CHV logbook, community registry, CHPS inventory log and meeting minutes will be conducted mainly at monthly review meeting. Direct observation will be accompanied with household survey and document review process. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
Current primary outcome measures as of 03/05/2019: |
| Key secondary outcome measure(s) |
Current secondary outcome measures as of 03/05/2019: |
| Completion date | 30/09/2016 |
Eligibility
| Participant type(s) | Other |
|---|---|
| Age group | Mixed |
| Sex | All |
| Target sample size at registration | 4000 |
| Total final enrolment | 3891 |
| Key inclusion criteria | Women aged 15-49 with at least 1 live birth in the past 5 years and children under 5 years |
| Key exclusion criteria | 1. Households without a woman aged 15-49 with at least 1 live birth in the past 5 years 2. Households rejecting participation of the study |
| Date of first enrolment | 18/04/2015 |
| Date of final enrolment | 04/05/2015 |
Locations
Countries of recruitment
- Ghana
- Korea, South
Study participating centres
Sujeong-gu
Seongnam-si
Gyeonggi-do
461-833
Korea, South
Ho
Volta region
-
Ghana
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | Data cannot be shared publicly because of Ghana government policy. Data are available from the Ghana Health Service (via Dr Anthony Ofosu, anthony.ofosu@ghsmail.org) for researchers who meet the criteria for access to confidential data. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 14/06/2019 | 17/06/2019 | Yes | No |
| Protocol article | protocol | 19/01/2017 | Yes | No | |
| Other publications | Economic evaluation | 11/05/2023 | 10/07/2023 | Yes | No |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
10/07/2023: Publication reference added.
17/06/2019: Publication reference and total final enrolment added.
07/05/2019: IPD sharing statement added.
03/05/2019: The following changes were made to the trial record:
1. The primary and secondary outcome measures were updated.
2. The overall trial start date was changed from 01/07/2015 to 01/02/2015.
3. The recruitment end date was changed from 31/08/2016 to 04/05/2015.
4. The overall trial end date was changed from 30/12/2016 to 30/09/2016.
23/01/2017: Publication reference added.
24/03/2016: Ethics approval information added.